Guest AuthorOctober 15, 2013
5min178
Ominous headlines on federal cuts to biomedical research are not exaggerating the consequences. These cuts mean tangible damage to fruitful research programs, laboratories and discoveries. It takes forever (OK, only a decade or two) for most drugs to progress from basic discovery through trials to federal approval. Seemingly small delays now translate into a loss […]